• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study

0
  • by alexperjescuadmin
  • in Cardiovascular
  • — 6 Nov, 2007
Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study
AudioMedica News
Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study
Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-373"/>
Uwe Zeymer
Uwe Zeymer
REFERENCE: Late Breaking Clinical Trials Session I, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
UWE ZEYMER, Herzzentrum Ludwigshafen, Germany
The glycoprotein 2B 3A antagonist eptifibatide has performed as well as standard abciximab therapy in patients receiving primary angioplasty for acute myocardial infarction. So according to Uwe Zeymer who presented findings on this it can be used in this setting just as it is already being used in elective PCI. Sarah Maxwell interviewed Dr Zeymer at the Orlando conference.

[audio:https://www.audiomedica.com/podcasting/cardio/071105UweZeymerPODCAST.mp3]
Share

Tags: abciximabacuteangioplastyantagonistcardiovascularmyocardialtherapiestherapyuwe zeymer

You may also like...

  • Remove Thrombus Before Primary Angioplasty! Remove Thrombus Before Primary Angioplasty! 15 Apr, 2008
  • Microalbuminuria: Undervalued As A Risk Assessment Tool Microalbuminuria: Undervalued As A Risk Assessment Tool 18 Jun, 2009
  • Fewer Major Bleeding Events with Bivalirudin For Patients with Acute Coronary Syndromes: The ACUITY study Fewer Major Bleeding Events with Bivalirudin For Patients with Acute Coronary Syndromes: The ACUITY study 3 May, 2007
  • Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk 28 Aug, 2016

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
  • Next story Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • ALK—Targeted Lung Cancer Drugs Benefited Real…
    • New Front Line Standard for Older Patients with…
  • Home
  • Cardiovascular
  • Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.